TR199700213A2 - 2-Aril sübstitüentli piridinler. - Google Patents
2-Aril sübstitüentli piridinler.Info
- Publication number
- TR199700213A2 TR199700213A2 TR97/00213A TR9700213A TR199700213A2 TR 199700213 A2 TR199700213 A2 TR 199700213A2 TR 97/00213 A TR97/00213 A TR 97/00213A TR 9700213 A TR9700213 A TR 9700213A TR 199700213 A2 TR199700213 A2 TR 199700213A2
- Authority
- TR
- Turkey
- Prior art keywords
- aryl substituted
- substituted pyridines
- pyridines
- pyridilaldehydes
- arteriosclerosis
- Prior art date
Links
- 150000003222 pyridines Chemical class 0.000 title abstract 3
- 239000003814 drug Substances 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 150000002902 organometallic compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Abstract
2-Aril sübstitüentli piridinler, piridilaldehidleri organometalik bilesiklerle reaksiyona sokmak ve sonra ürünleri seçimli olarak indirgemek suretiyle hazirlanirlar. 2-Aril sübstitüentli piridinler ilaçlar, özellikle arteryosklerozun tedavisinde kullanima mahsus ilaçlar içinde aktif bilesikler olarak uygundurlar.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19610932A DE19610932A1 (de) | 1996-03-20 | 1996-03-20 | 2-Aryl-substituierte Pyridine |
Publications (1)
Publication Number | Publication Date |
---|---|
TR199700213A2 true TR199700213A2 (tr) | 1997-10-21 |
Family
ID=7788843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR97/00213A TR199700213A2 (tr) | 1996-03-20 | 1997-03-20 | 2-Aril sübstitüentli piridinler. |
Country Status (30)
Country | Link |
---|---|
US (2) | US5925645A (tr) |
EP (1) | EP0796846B1 (tr) |
JP (1) | JPH09255574A (tr) |
AR (1) | AR006318A1 (tr) |
AT (1) | ATE194832T1 (tr) |
AU (1) | AU1628097A (tr) |
BG (1) | BG101339A (tr) |
BR (1) | BR9701348A (tr) |
CA (1) | CA2200175A1 (tr) |
CO (1) | CO4520282A1 (tr) |
CZ (1) | CZ84397A3 (tr) |
DE (2) | DE19610932A1 (tr) |
DK (1) | DK0796846T3 (tr) |
EE (1) | EE9700060A (tr) |
ES (1) | ES2150157T3 (tr) |
GR (1) | GR3034546T3 (tr) |
HR (1) | HRP970105A2 (tr) |
HU (1) | HUP9700610A1 (tr) |
ID (1) | ID16292A (tr) |
IL (1) | IL120468A0 (tr) |
MY (1) | MY132490A (tr) |
NO (1) | NO971269L (tr) |
NZ (1) | NZ314419A (tr) |
PL (1) | PL319050A1 (tr) |
PT (1) | PT796846E (tr) |
SG (1) | SG50805A1 (tr) |
SK (1) | SK36197A3 (tr) |
TN (1) | TNSN97048A1 (tr) |
TR (1) | TR199700213A2 (tr) |
ZA (1) | ZA972375B (tr) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6268392B1 (en) | 1994-09-13 | 2001-07-31 | G. D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |
US6262277B1 (en) | 1994-09-13 | 2001-07-17 | G.D. Searle And Company | Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
US6642268B2 (en) | 1994-09-13 | 2003-11-04 | G.D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors |
AR008789A1 (es) * | 1996-07-31 | 2000-02-23 | Bayer Corp | Piridinas y bifenilos substituidos |
JP2894445B2 (ja) * | 1997-02-12 | 1999-05-24 | 日本たばこ産業株式会社 | Cetp活性阻害剤として有効な化合物 |
DE19709125A1 (de) * | 1997-03-06 | 1998-09-10 | Bayer Ag | Substituierte Chinoline |
WO1999041237A1 (en) * | 1998-02-13 | 1999-08-19 | G.D. Searle & Co. | Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity |
JP4546589B2 (ja) * | 1998-04-23 | 2010-09-15 | 武田薬品工業株式会社 | ナフタレン誘導体 |
CA2345118C (en) * | 1998-09-25 | 2010-04-27 | Monsanto Company | Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
ATE242007T1 (de) | 1998-12-23 | 2003-06-15 | Searle Llc | Kombinationen von cholesteryl ester transfer protein inhibitoren und nicotinsäure derivaten für kardiovaskuläre indikationen |
AU2157400A (en) | 1998-12-23 | 2000-07-31 | G.D. Searle & Co. | Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications |
EA009466B1 (ru) | 1998-12-23 | 2007-12-28 | Джи.Ди. Сирл Ллс | Ингибитор белка, переносящего эфир холестерила |
PL348580A1 (en) | 1998-12-23 | 2002-06-03 | Searle Llc | Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indications |
CA2356240C (en) | 1998-12-23 | 2008-04-01 | G.D. Searle Llc | Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications |
HUP0201972A3 (en) | 1998-12-23 | 2005-06-28 | G D Searle Llc Chicago | Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications |
DK1140190T3 (da) | 1998-12-23 | 2002-12-23 | Searle Llc | Kombinationer af ileumgaldesyretransport-inhibitorer og galdesyre-sekvestreringsmidler til cardiovaskulære indikatorer |
US6924313B1 (en) | 1999-09-23 | 2005-08-02 | Pfizer Inc. | Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
US6683113B2 (en) * | 1999-09-23 | 2004-01-27 | Pharmacia Corporation | (R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
US20010018446A1 (en) | 1999-09-23 | 2001-08-30 | G.D. Searle & Co. | Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
WO2001068637A2 (en) | 2000-03-10 | 2001-09-20 | Pharmacia Corporation | Method for the preparation of tetrahydrobenzothiepines |
WO2003024441A1 (fr) * | 2001-09-14 | 2003-03-27 | Shionogi & Co., Ltd. | Nouvelle utilisation de composes tricycliques |
US7115279B2 (en) | 2000-08-03 | 2006-10-03 | Curatolo William J | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
KR100759635B1 (ko) | 2001-06-22 | 2007-09-17 | 화이자 프로덕츠 인코포레이티드 | 비정질 약물의 흡착체의 약학 조성물 |
EP1404300B1 (en) | 2001-06-22 | 2009-09-30 | Pfizer Products Inc. | Pharmaceutical compositions of dispersions of drugs and neutral polymers |
EP1269994A3 (en) | 2001-06-22 | 2003-02-12 | Pfizer Products Inc. | Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
BR0213501A (pt) | 2001-11-02 | 2004-08-24 | Searle Llc | Compostos de benzotiepina mono- e di-fluorada como inibidores de transporte de ácido biliar co-dependente de sódio apical (asbt) e captação de taurocolato |
AU2003207431A1 (en) | 2002-01-17 | 2003-09-02 | Pharmacia Corporation | Novel alkyl/aryl hydroxy or keto thiepines. |
ATE395044T1 (de) | 2002-02-01 | 2008-05-15 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien |
AR038375A1 (es) | 2002-02-01 | 2005-01-12 | Pfizer Prod Inc | Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo |
ES2310676T3 (es) | 2002-12-20 | 2009-01-16 | Pfizer Products Inc. | Formas de dosificacion que comprenden un inhibidor de cetp y un inhibidor de hmg-coa reductasa. |
WO2004082593A2 (en) | 2003-03-17 | 2004-09-30 | Japan Tobacco Inc. | Pharmaceutical compositions of cetp inhibitors |
MXPA05009976A (es) * | 2003-03-17 | 2005-11-04 | Japan Tobacco Inc | Metodo para incrementar la biodisponibilidad oral del 2-metilpropantioato de s-[2-([[1- 2-etilbutil) ciclohexil] carbonil] amino) fenilo]. |
TWI494102B (zh) * | 2003-05-02 | 2015-08-01 | Japan Tobacco Inc | 包含s-〔2(〔〔1-(2-乙基丁基)環己基〕羰基〕胺基)苯基〕2-甲基丙烷硫酯及hmg輔酶a還原酶抑制劑之組合 |
ATE540671T1 (de) | 2003-08-04 | 2012-01-15 | Bend Res Inc | Pharmazeutische zusammensetzungen von adsorbaten von amorphen arzneimitteln und lipophilen mikrophasen-bildenden materialien |
CL2004001884A1 (es) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
MXPA06003357A (es) | 2003-09-26 | 2006-06-08 | Japan Tobacco Inc | Metodo para inhibir la produccion de lipoproteina remanente. |
TW200523252A (en) * | 2003-10-31 | 2005-07-16 | Takeda Pharmaceutical | Pyridine compounds |
FR2873368B1 (fr) * | 2004-07-26 | 2008-01-04 | Merck Sante Soc Par Actions Si | Derives de guanidine et leurs utilisations en therapeutique |
RU2393151C2 (ru) * | 2004-12-18 | 2010-06-27 | Байер Шеринг Фарма Акциенгезельшафт | 4-циклоалкилзамещенные производные тетрагидрохинолина и их применение в качестве лекарств |
US8617604B2 (en) | 2005-02-03 | 2013-12-31 | Bend Research, Inc. | Pharmaceutical compositions with enhanced performance |
US7737155B2 (en) | 2005-05-17 | 2010-06-15 | Schering Corporation | Nitrogen-containing heterocyclic compounds and methods of use thereof |
US20080255084A1 (en) | 2005-10-21 | 2008-10-16 | Randy Lee Webb | Combination of Organic Compounds |
EP1815919A1 (en) * | 2006-02-03 | 2007-08-08 | Uponor Innovation Ab | Making an elongated product |
DE102006012548A1 (de) * | 2006-03-18 | 2007-09-20 | Bayer Healthcare Ag | Substituierte Chromanol-Derivate und ihre Verwendung |
US20110245209A1 (en) | 2008-12-16 | 2011-10-06 | Schering Corporation | Pyridopyrimidine derivatives and methods of use thereof |
EP2379562A1 (en) | 2008-12-16 | 2011-10-26 | Schering Corporation | Bicyclic pyranone derivatives as nicotinic acid receptor agonists |
JP5785560B2 (ja) | 2009-12-21 | 2015-09-30 | バイエル・クロップサイエンス・アクチェンゲゼルシャフト | 殺真菌剤としてのビス(ジフルオロメチル)ピラゾール |
US8815775B2 (en) | 2010-05-18 | 2014-08-26 | Bayer Cropscience Ag | Bis(difluoromethyl)pyrazoles as fungicides |
US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
CN107074841B (zh) | 2014-08-11 | 2021-03-26 | 安吉恩生物医药公司 | 细胞色素p450抑制剂及其用途 |
US10287282B2 (en) * | 2014-12-31 | 2019-05-14 | Angion Biomedica Corp. | Methods and agents for treating disease |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5169857A (en) * | 1988-01-20 | 1992-12-08 | Bayer Aktiengesellschaft | 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis |
GB8626344D0 (en) * | 1986-11-04 | 1986-12-03 | Zyma Sa | Bicyclic compounds |
EP0307342B1 (de) * | 1987-07-10 | 1996-01-03 | Hoechst Aktiengesellschaft | 3-Desmethyl-mevalonsäurederivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen, ihre Verwendung sowie Zwischenprodukte |
US4906624A (en) * | 1987-09-08 | 1990-03-06 | Warner-Lambert Company | 6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis |
NO177005C (no) * | 1988-01-20 | 1995-07-05 | Bayer Ag | Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen |
NZ230121A (en) * | 1988-08-29 | 1993-08-26 | Squibb & Sons Inc | Pyridine and quinoline terminal groups for hmg-coenzyme a reductase inhibitors and pharmaceutical compositions for lowering blood serum cholesterol levels |
DE4244029A1 (de) * | 1992-12-24 | 1994-06-30 | Bayer Ag | Neue substituierte Pyridine |
-
1996
- 1996-03-20 DE DE19610932A patent/DE19610932A1/de not_active Withdrawn
-
1997
- 1997-02-25 HR HR19610932.9A patent/HRP970105A2/hr not_active Application Discontinuation
- 1997-03-07 EP EP97103813A patent/EP0796846B1/de not_active Expired - Lifetime
- 1997-03-07 DE DE59702034T patent/DE59702034D1/de not_active Expired - Fee Related
- 1997-03-07 PT PT97103813T patent/PT796846E/pt unknown
- 1997-03-07 DK DK97103813T patent/DK0796846T3/da active
- 1997-03-07 AT AT97103813T patent/ATE194832T1/de not_active IP Right Cessation
- 1997-03-07 ES ES97103813T patent/ES2150157T3/es not_active Expired - Lifetime
- 1997-03-13 US US08/816,290 patent/US5925645A/en not_active Expired - Fee Related
- 1997-03-13 AU AU16280/97A patent/AU1628097A/en not_active Abandoned
- 1997-03-14 SG SG1997000783A patent/SG50805A1/en unknown
- 1997-03-17 IL IL12046897A patent/IL120468A0/xx unknown
- 1997-03-17 NZ NZ314419A patent/NZ314419A/xx unknown
- 1997-03-17 CA CA002200175A patent/CA2200175A1/en not_active Abandoned
- 1997-03-17 JP JP9082454A patent/JPH09255574A/ja not_active Ceased
- 1997-03-18 BG BG101339A patent/BG101339A/xx unknown
- 1997-03-18 TN TNTNSN97048A patent/TNSN97048A1/fr unknown
- 1997-03-19 NO NO971269A patent/NO971269L/no unknown
- 1997-03-19 AR ARP970101096A patent/AR006318A1/es unknown
- 1997-03-19 CZ CZ97843A patent/CZ84397A3/cs unknown
- 1997-03-19 BR BR9701348A patent/BR9701348A/pt not_active Application Discontinuation
- 1997-03-19 ZA ZA9702375A patent/ZA972375B/xx unknown
- 1997-03-19 MY MYPI97001168A patent/MY132490A/en unknown
- 1997-03-19 PL PL97319050A patent/PL319050A1/xx unknown
- 1997-03-19 SK SK361-97A patent/SK36197A3/sk unknown
- 1997-03-19 HU HU9700610A patent/HUP9700610A1/hu unknown
- 1997-03-20 TR TR97/00213A patent/TR199700213A2/tr unknown
- 1997-03-20 EE EE9700060A patent/EE9700060A/xx unknown
- 1997-03-20 ID IDP970913A patent/ID16292A/id unknown
- 1997-03-20 CO CO97015054A patent/CO4520282A1/es unknown
-
1998
- 1998-12-21 US US09/217,214 patent/US6127383A/en not_active Expired - Fee Related
-
2000
- 2000-10-04 GR GR20000402236T patent/GR3034546T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5925645A (en) | 1999-07-20 |
SG50805A1 (en) | 1998-07-20 |
ZA972375B (en) | 1997-09-25 |
SK36197A3 (en) | 1997-11-05 |
CZ84397A3 (en) | 1997-10-15 |
DE59702034D1 (de) | 2000-08-24 |
JPH09255574A (ja) | 1997-09-30 |
CA2200175A1 (en) | 1997-09-20 |
US6127383A (en) | 2000-10-03 |
PT796846E (pt) | 2000-12-29 |
DE19610932A1 (de) | 1997-09-25 |
EP0796846A1 (de) | 1997-09-24 |
MX9702042A (es) | 1997-09-30 |
BG101339A (en) | 1998-04-30 |
CO4520282A1 (es) | 1997-10-15 |
HU9700610D0 (en) | 1997-05-28 |
NO971269L (no) | 1997-09-22 |
IL120468A0 (en) | 1997-07-13 |
MY132490A (en) | 2007-10-31 |
TNSN97048A1 (fr) | 2005-03-15 |
AU1628097A (en) | 1997-09-25 |
HRP970105A2 (en) | 1998-04-30 |
EE9700060A (et) | 1997-10-15 |
AR006318A1 (es) | 1999-08-25 |
BR9701348A (pt) | 1998-11-10 |
ID16292A (id) | 1997-09-18 |
GR3034546T3 (en) | 2001-01-31 |
NO971269D0 (no) | 1997-03-19 |
HUP9700610A1 (hu) | 2000-08-28 |
EP0796846B1 (de) | 2000-07-19 |
PL319050A1 (en) | 1997-09-29 |
DK0796846T3 (da) | 2000-10-23 |
NZ314419A (en) | 1998-12-23 |
ES2150157T3 (es) | 2000-11-16 |
ATE194832T1 (de) | 2000-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199700213A2 (tr) | 2-Aril sübstitüentli piridinler. | |
MY129973A (en) | Sulphonylbenzyl-substituted pyridones. | |
CA2148928A1 (en) | Pharmacologically active pyridine derivatives and processes for the preparation thereof | |
MY131014A (en) | Heterocyclic-fused pyridines | |
ATE494009T1 (de) | Prodrugs, ihre herstellung und verwendung als arzneimittel | |
DE69715888D1 (de) | Pyridylalken- und pyridylalkin-säureamide als cytostatika und immunosuppressive arzneimittel | |
NZ239514A (en) | Oxazole-substituted hydroxy-urea and cyclised hydroxy-urea derivatives, intermediate compounds and medicaments | |
TR200103525T2 (tr) | Bisiklik poliaminosit metal kompleksleri, bunları hazırlamak için yöntem ve bunların tıbbi görüntülemede kullanımı. | |
DK0425650T3 (da) | Antiinflammatoriske 4-aminophenolderivater | |
NO934706D0 (no) | Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner | |
AU2861389A (en) | Disubstituted pyridines | |
DE59107336D1 (de) | Oligosaccharidderivate und deren Verwendung in Heilmitteln | |
GR3036287T3 (en) | Substituted imidazo(4,5-b)pyridines and benzimidazoles as angiotensin II antagonistes. | |
ATE94764T1 (de) | Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung. | |
ES2175006T3 (es) | N-(pirimidinil)-benzosulfonamidas como medicamentos. | |
GR3017967T3 (en) | Substituted pyrido-oxazines. | |
TW245713B (tr) | ||
WO2000069841A3 (en) | Benzofuranylaminoalcohols | |
DK0579939T3 (da) | Phospholipidderivater | |
NO870398D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive organiskeplatinakomplekser. | |
MY132270A (en) | Substituted indole derivatives | |
GR920100423A (el) | Ανταγωνιστές 5-ΗΤ4 κινολιζιδινυλ εστέρος. | |
ECSP972060A (es) | Piridinas sustituidas por 2-arilo (ilea 31420-ec) | |
DE59609482D1 (de) | Anellierte beta-carboline |